Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)

Inclusion Criteria: Women with prolapse electing to undergo reconstructive vaginal surgery for primary uterovaginal prolapse, who wish to enroll in this trial of an incision-free prolapse repair technique, after being familiarized with the suspected benefits and risks of the procedure. * Ages 18-90 years old * POP-Q Stage 2 or greater with an apical support defect, also defined as uterovaginal prolapse * Desire of uterine preservation * Patient is willing to return for follow-up evaluation and questionnaire completion at 3 months, 6 months, and 12 months, in addition to routine postoperative standard of care. * English fluency Exclusion Criteria: * Previous vaginal, abdominal, or laparoscopic repair for pelvic organ prolapse * Prior hysterectomy * Known allergy to Nitinol / Stainless Steel / Polydioxanone. * Suspected uterine pathology, including malignancy. * History of chronic pelvic pain, interstitial cystitis or fibromyalgia. * Women diagnosed with symptomatic uterine fibroids, cervical elongation or hypertrophy, abnormal uterine or vaginal bleeding. * History of Pelvic Inflammatory Disease (PID) * Prior pelvic radiation therapy or malignancy. * Diagnosis of reproductive tract anomalies. * Pregnant or lactating women. * Participation in another trial * Inability to provide informed consent for study enrollment * PI's subjective assessment that study procedure will not plausibly correct patient pelvic organ prolapse symptoms due to anatomic considerations